Business
Should Cannabis Be Part Of Hospice Care?
A life-threatening illness is one of the most frightening experiences anyone can go through. No one wants to be diagnosed with a terminal illness, and no one wants someone they love diagnosed with the same thing. For almost 2 million people each year, they enter hospice for the last part of their life. It is hard on the patient and the loved ones. Should cannabis be part of hospice care? In some legal states, hospice staff are allowing marijuana to ease suffering, especially for cancer.
As Americans continue to age, the risks of terminal illnesses increase with more people getting admitted to hospitals and hospices. The Centers for Disease Control (CDC) announced that there are an estimated 1.7+ million people in hospices receiving care from varying life-threatening illnesses. This number is a tremendous increase from what was obtainable in the last 20 years. In those hospices, the patients receive a special kind of care that slows the painful process.
The care given to patients is provided by compassionate individuals who are 100% available to make the last life phases very comfortable. While these hospices are doing their best, there are still instances where some patients don’t get better with the care they receive.
Of course, this is a problematic situation, and it has made medical experts seek solutions for hospices, and marijuana is one of the most viable ideas they explore.
Despite the good intentions, the legal status of marijuana affects its use and effectiveness in hospices. For example, although some states have legalized marijuana, it is still not legally accepted at the federal level. The federal level’s lack of support makes it difficult for some healthcare providers to prescribe cannabis for their patients in hospices.
Marijuana in hospices
Marijuana is utilized in hospice care to ease patients suffering as it plays a significant therapeutic role for patients dealing with the emotional despair that comes with a terminal illness.
Hospices are turning to marijuana as a way of reinventing their approach to Medicare for patients. These hospices want a more patient-centric care experience that eradicates the idea that they are cold, ineffective, and unwelcome.
Therefore, hospices in America need to incorporate more effective treatment and care options that help them feel like they are making daily progress. In addition to marijuana, the hospices also integrate additional treatment options such as music, thoughtful quality care, and family moments to make the treatment options relatable.

But medical marijuana has become a new focus for these hospices. As Americans’ attitudes towards marijuana change (from suspicion to acceptance), more hospices are encouraged to consider it as a treatment option.
Currently, 87% of Americans support the utilization of medical marijuana as a treatment option for terminally sick patients. More so, three in five Americans (this is about 58%) express strong support for medical marijuana. So how do hospices use marijuana?
How hospices use marijuana
Primarily, hospices use marijuana as a care treatment alternative to ease the patient’s spiritual and existential suffering. The mild euphoria marijuana offers give the patient a sense of well-being which eases the body, mind, and spirit as they come to terms with the possibility of death.
In 2019, a study showed the impact of cannabis and CBD on hospice and palliative care places, with data drawn from over 300 care professionals from 40 American States. The professionals offered “overwhelming support” for marijuana use in hospices regardless of its legal status in the state.
With such factual details and preference for marijuana in hospices, one can only ask, “How does it help those in the hospices?” Here are answers to that question:
Pain reduction in patients
Pain reduction is one of the most prominent benefits of marijuana used in hospices. The patients sometimes experience excruciating pain, which masks them uncomfortable, making their stay at the hospice unpleasant.
But with medical marijuana treatment, pain is reduced and replaced with a euphoric sensation that eases the patient’s mind, thus making them numb to pain. This health benefit of marijuana can only be effective when the substance is used consistently.
Enhancement of the senses
Cannabis is an enhancer that heightens patient sensory perceptions and awareness, thus leading to a better appreciation of tastes, senses, and music. Remember that some people in hospices are older individuals who gradually lose their ability to recognize feelings and their sense of taste. But when marijuana is administered, the patient’s sense of awareness is heightened, enabling them to appreciate every moment even as their days are numbered.

Increases appetite
The patients in hospices often struggle with their appetite because of the intense treatments (for example, cancer patients). Decreased appetite is also prevalent because they are emotionally down, with the illnesses taking a toll on their mental health. But CBD is an appetite-boosting compound that encourages them to eat regularly and also snack in between meals. A hospice patient will have a greater chance of better managing illness when he or she consistently eats nutritious meals.
Eases anxiety
Anxiety is a common symptom that hospice patients experience due to the fear of death and worries about their families. But when medical marijuana is administered the THC and CBD, it contains impacts such as anxiety levels.
THC, when given in smaller doses, decreases anxiety, and CBD also does the same, thus helping the patient feel relaxed and calm, which provides a significant boost to their health.
Bottom Line
Medical experts are increasingly excited at the enormous potential of marijuana. Globally, people are beginning to appreciate the value of cannabis. Marijuana products that have been tested and approved for use should be well-integrated into the healthcare system because of their immense benefits.
Experts and caregivers at hospices derive incredible benefits from cannabis. Both of the plant’s recreational and medicinal properties are highly valued by caregivers and patients. However, for marijuana to reach its lofty potential in hospices in the future, there must be a unified legal status of cannabis from federal to state levels.
Until we have such a unified status, marijuana will continue to impact the lives of hospice patients in the ways currently available, helping them manage their terminal illnesses.
Source: https://thefreshtoast.com/medical-marijuana/should-cannabis-be-part-of-hospice-care/
Business
Alleged Crores Pharma Scam Mastermind Arrested from Surat
After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.
Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.
Fake Business Deals and Dishonoured Cheques Used in Fraud
Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.
In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”
Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.
Multiple Identities and Repeated Fraud Pattern
Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.
Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.
Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.
Multi-State Surveillance Leads to Arrest in Surat
A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.
Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.
Growing Threat of Corporate Identity Fraud
The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.
Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.
Experts Urge Stronger Due Diligence in High-Value Transactions
Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.
Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.
Business
EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices
A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.
Investigation Under Digital Markets Act Gains Momentum
The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.
Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.
Industry Groups Demand Swift Action
Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.
Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.
In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.
Google Denies Allegations
Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.
However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.
Potential Billion-Euro Penalties
If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.
Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.
Wider Implications for Big Tech
The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.
A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.
As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.
AI & Technology
Amazon Faces Potential Criminal Trial in Italy Over €1.2 Billion Tax Evasion Allegations
Milan: U.S. tech giant Amazon is facing the prospect of a major legal showdown in Italy, after prosecutors in Milan formally requested a court to move forward with criminal proceedings over alleged tax evasion totaling approximately ₹12,500 crore (€1.2 billion).
The case targets Amazon’s European division along with four senior executives, marking one of the most significant tax-related investigations involving a global e-commerce platform in Europe.
Trial Push Despite Multi-Million Euro Settlement
The move comes even after Amazon reached a financial settlement with Italian tax authorities in December, agreeing to pay around ₹5,500 crore (€527 million), including interest, to resolve part of the dispute.
Typically, such settlements lead to the closure of criminal investigations. However, Milan prosecutors have opted to proceed, signaling a tougher stance on alleged corporate tax violations.
A preliminary hearing is expected in the coming months, where a judge will decide whether to formally indict the company and its executives or dismiss the case.
Allegations of VAT Evasion Through Marketplace Sellers
At the center of the investigation are claims that Amazon’s platform enabled non-European Union sellers to avoid paying value-added tax (VAT) on goods sold to Italian consumers between 2019 and 2021.
Prosecutors allege that the company’s marketplace structure allowed thousands of foreign vendors—many reportedly based in China—to operate without fully disclosing their identities or tax obligations. This, authorities argue, led to substantial VAT losses for the Italian government.
Under Italian law, online platforms facilitating sales can be held partially liable if third-party sellers fail to comply with tax requirements, a key point in the prosecution’s case.
Italian Government Named as Affected Party
In their filing, prosecutors identified Italy’s Economy Ministry as the injured party, citing significant financial damage resulting from the alleged tax evasion.
Legal experts say the outcome of the case could have wide-ranging implications across the European Union, where VAT systems are harmonized and similar compliance rules apply to digital marketplaces.
Multiple Investigations Add to Pressure
The VAT probe is just one of several legal challenges facing Amazon in Italy. The European Public Prosecutor’s Office is reportedly examining additional tax-related issues covering more recent years.
Meanwhile, Milan authorities are pursuing separate investigations into alleged customs fraud linked to imports from China and whether Amazon maintained an undeclared “permanent establishment” in Italy—potentially exposing it to higher tax liabilities.
In a separate regulatory action, Italy’s data protection authority recently ordered an Amazon unit to stop using personal data from over 1,800 employees at a warehouse near Rome.
Amazon Denies Allegations
Amazon has consistently denied wrongdoing and indicated it will strongly contest the allegations in court if the case proceeds. The company has also warned that prolonged legal uncertainty could impact investor confidence and Italy’s appeal as a destination for international business.
Broader Impact on Europe’s Digital Economy
If the case moves to trial, it could become a landmark moment for the regulation of global e-commerce platforms in Europe. Governments across the region are increasingly scrutinizing how digital marketplaces handle tax compliance, especially in cross-border transactions.
With online retail continuing to expand, regulators are under mounting pressure to ensure that multinational platforms and third-party sellers adhere to the same tax rules as traditional businesses.
-
Business3 years agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business3 years agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business3 years agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business3 years agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business3 years agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business3 years agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business3 years agoCan Cannabis Help Seasonal Depression
-
Blogs3 years agoCannabis Art Is Flourishing On Etsy
